Literature DB >> 19647037

The nuclear appearance of ERK1/2 and p38 determines the sequential induction of ATF2-Thr71 and ATF2-Thr69 phosphorylation by serum in JNK-deficient cells.

Bart Baan1, Gerard C M van der Zon, J Antonie Maassen, D Margriet Ouwens.   

Abstract

Growth factors activate ATF2 via sequential phosphorylation of Thr69 and Thr71, where the ATF2-Thr71-phosphorylation precedes the induction of ATF2-Thr69+71-phosphorylation. Here, we studied the mechanisms contributing to serum-induced two-step ATF2-phosphorylation in JNK1,2-deficient embryonic fibroblasts. Using anion exchange chromatography, ERK1/2 and p38 were identified as ATF2-kinases in vitro. Inhibitor studies as well as nuclear localization experiments show that the sequential nuclear appearance of ERK1/2 and p38 determines the induction of ATF2-Thr71 and ATF2-Thr69+71-phosphorylation in response to serum.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19647037     DOI: 10.1016/j.mce.2009.07.023

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  8 in total

Review 1.  Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: Strategies to treat sickle cell disease.

Authors:  Betty S Pace; Li Liu; Biaoru Li; Levi H Makala
Journal:  Exp Biol Med (Maywood)       Date:  2015-08

2.  The unfolded protein response and the phosphorylations of activating transcription factor 2 in the trans-activation of il23a promoter produced by β-glucans.

Authors:  Mario Rodríguez; Esther Domingo; Sara Alonso; Javier García Frade; José Eiros; Mariano Sánchez Crespo; Nieves Fernández
Journal:  J Biol Chem       Date:  2014-06-30       Impact factor: 5.157

3.  Inhibition of p38-MAPK alters SRC coactivation and estrogen receptor phosphorylation.

Authors:  James W Antoon; Melyssa R Bratton; Lori M Guillot; Scott Wadsworth; Virgilio A Salvo; Matthew E Burow
Journal:  Cancer Biol Ther       Date:  2012-07-24       Impact factor: 4.742

4.  Precisely ordered phosphorylation reactions in the p38 mitogen-activated protein (MAP) kinase cascade.

Authors:  John M Humphreys; Alexander T Piala; Radha Akella; Haixia He; Elizabeth J Goldsmith
Journal:  J Biol Chem       Date:  2013-06-06       Impact factor: 5.157

5.  A cytoplasmic negative regulator isoform of ATF7 impairs ATF7 and ATF2 phosphorylation and transcriptional activity.

Authors:  Jessica Diring; Barbara Camuzeaux; Mariel Donzeau; Marc Vigneron; Manuel Rosa-Calatrava; Claude Kedinger; Bruno Chatton
Journal:  PLoS One       Date:  2011-08-16       Impact factor: 3.240

6.  The ROS/JNK/ATF2 pathway mediates selenite-induced leukemia NB4 cell cycle arrest and apoptosis in vitro and in vivo.

Authors:  J J An; K J Shi; W Wei; F Y Hua; Y L Ci; Q Jiang; F Li; P Wu; K Y Hui; Y Yang; C M Xu
Journal:  Cell Death Dis       Date:  2013-12-19       Impact factor: 8.469

Review 7.  The activating transcription factor 2: an influencer of cancer progression.

Authors:  Kerstin Huebner; Jan Procházka; Ana C Monteiro; Vijayalakshmi Mahadevan; Regine Schneider-Stock
Journal:  Mutagenesis       Date:  2019-12-19       Impact factor: 3.000

8.  Aberration of the modulatory functions of intronic microRNA hsa-miR-933 on its host gene ATF2 results in type II diabetes mellitus and neurodegenerative disease development.

Authors:  Abul Bashar Mir Md Khademul Islam; Eusra Mohammad; Md Abdullah-Al-Kamran Khan
Journal:  Hum Genomics       Date:  2020-09-29       Impact factor: 4.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.